Related references
Note: Only part of the references are listed.Recent Developments in 3D Bio-Printing and Its Biomedical Applications
Humira Assad et al.
PHARMACEUTICS (2023)
GelMA, Click-Chemistry Gelatin and Bioprinted Polyethylene Glycol-Based Hydrogels as 3D Ex Vivo Drug Testing Platforms for Patient-Derived Breast Cancer Organoids
Nathalie Bock et al.
PHARMACEUTICS (2023)
Comparative Analysis of Dasatinib Effect between 2D and 3D Tumor Cell Cultures
Samantha Sabetta et al.
PHARMACEUTICS (2023)
Stereolithography apparatus and digital light processing-based 3D bioprinting for tissue fabrication
Wanlu Li et al.
ISCIENCE (2023)
Poor Translatability of Biomedical Research Using Animals - A Narrative Review
Lindsay J. Marshall et al.
ATLA-ALTERNATIVES TO LABORATORY ANIMALS (2023)
High cell density and high-resolution 3D bioprinting for fabricating vascularized tissues
Shangting You et al.
SCIENCE ADVANCES (2023)
Cancer statistics, 2022
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2022)
Bioprinted Cancer Model of Neuroblastoma in a Renal Microenvironment as an Efficiently Applicable Drug Testing Platform
Dongwei Wu et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)
Development and evaluation of a multicomponent bioink consisting of alginate, gelatin, diethylaminoethyl cellulose and collagen peptide for 3D bioprinting of tissue construct for drug screening application
Rency Geevarghese et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES (2022)
Human organs-on-chips for disease modelling, drug development and personalized medicine
Donald E. Ingber
NATURE REVIEWS GENETICS (2022)
3D bioprinted, vascularized neuroblastoma tumor environment in fluidic chip devices for precision medicine drug testing
Daniel Nothdurfter et al.
BIOFABRICATION (2022)
Advances in 3D Bioprinting for Cancer Biology and Precision Medicine: From Matrix Design to Application
MoonSun Jung et al.
ADVANCED HEALTHCARE MATERIALS (2022)
Evaluating the Suitability of 3D Bioprinted Samples for Experimental Radiotherapy: A Pilot Study
Munir A. Al-Zeer et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)
Polysaccharide hydrogel based 3D printed tumor models for chemotherapeutic drug screening
Aragaw Gebeyehu et al.
SCIENTIFIC REPORTS (2021)
3D Liver Tissue Model with Branched Vascular Networks by Multimaterial Bioprinting
Xin Liu et al.
ADVANCED HEALTHCARE MATERIALS (2021)
3D Bioprinting of Human Tissues: Biofabrication, Bioinks, and Bioreactors
Jianhua Zhang et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
3D bioprinting: novel approaches for engineering complex human tissue equivalents and drug testing
Judith Hagenbuchner et al.
3D BIOPRINTING (2021)
Combination of Gemcitabine and Thymosin alpha 1 exhibit a better anti-tumor effect on nasal natural killer/T-cell lymphoma
Meiyu Chen et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2021)
Bioprinted Multi-Cell Type Lung Model for the Study of Viral Inhibitors
Johanna Berg et al.
VIRUSES-BASEL (2021)
Pseudoprogression and Hyperprogression as New Forms of Response to Immunotherapy
Maxime Frelaut et al.
BIODRUGS (2020)
Molecular therapeutic targets in non-small cell lung cancer
Kamya Sankar et al.
EXPERT REVIEW OF ANTICANCER THERAPY (2020)
Non-Small-Cell Lung Cancer Signaling Pathways, Metabolism, and PD-1/PD-L1 Antibodies
Mariacarmela Santarpia et al.
CANCERS (2020)
Vascular bioprinting with enzymatically degradable bioinks via multi-material projection-based stereolithography
Alexander Thomas et al.
ACTA BIOMATERIALIA (2020)
3D-Printed Bubble-Free Perfusion Cartridge System for Live-Cell Imaging
Daigo Terutsuki et al.
SENSORS (2020)
The Resistance Mechanisms of Lung Cancer Immunotherapy
Fen Wang et al.
FRONTIERS IN ONCOLOGY (2020)
Estimation of clinical trial success rates and related parameters
Chi Heem Wong et al.
BIOSTATISTICS (2019)
Emerging therapies for non-small cell lung cancer
Chao Zhang et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2019)
Systemic Therapy for Locally Advanced and Metastatic Non-Small Cell Lung Cancer A Review
Kathryn C. Arbour et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2019)
The effect of 2D and 3D cell cultures on treatment response, EMT profile and stem cell features in head and neck cancer
Styliani Melissaridou et al.
CANCER CELL INTERNATIONAL (2019)
3D organ models-Revolution in pharmacological research?
Marie Weinhart et al.
PHARMACOLOGICAL RESEARCH (2019)
Current WHO guidelines and the critical role of immunohistochemical markers in the subclassification of non-small cell lung carcinoma (NSCLC): Moving from targeted therapy to immunotherapy
Lais Osmani et al.
SEMINARS IN CANCER BIOLOGY (2018)
Generation of a 3D Liver Model Comprising Human Extracellular Matrix in an Alginate/Gelatin-Based Bioink by Extrusion Bioprinting for Infection and Transduction Studies
Thomas Hiller et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
The biology and management of non-small cell lung cancer
Roy S. Herbst et al.
NATURE (2018)
3D Bioprinting for Organ Regeneration
Haitao Cui et al.
ADVANCED HEALTHCARE MATERIALS (2017)
Bendamustine in Combination With Gemcitabine and Vinorelbine Is an Effective Regimen As Induction Chemotherapy Before Autologous Stem-Cell Transplantation for Relapsed or Refractory Hodgkin Lymphoma: Final Results of a Multicenter Phase II Study
Armando Santoro et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
The biology and function of fibroblasts in cancer
Raghu Kalluri
NATURE REVIEWS CANCER (2016)
Tissue Vascularization Through 3D Printing: Will Technology Bring Us Flow?
S. J. Paulsen et al.
DEVELOPMENTAL DYNAMICS (2015)
A microfluidic bubble trap and oscillator
Janick D. Stucki et al.
LAB ON A CHIP (2015)
Comparison of 2D-and 3D-culture models as drug-testing platforms in breast cancer
Yoshinori Imamura et al.
ONCOLOGY REPORTS (2015)
Spontaneously-forming spheroids as an in vitro cancer cell model for anticancer drug screening
Maria A. Theodoraki et al.
ONCOTARGET (2015)
p38 and JNK MAPK pathways control the balance of apoptosis and autophagy in response to chemotherapeutic agents
Xinbing Sui et al.
CANCER LETTERS (2014)
Building Vascular Networks
Hojae Bae et al.
SCIENCE TRANSLATIONAL MEDICINE (2012)
Activity of Anticancer Agents in a Three-Dimensional Cell Culture Model
Victor Sanjit Nirmalanandhan et al.
ASSAY AND DRUG DEVELOPMENT TECHNOLOGIES (2010)
KRAS Mutant Lung Cancer Cells Are Differentially Responsive to MEK Inhibitor Due to AKT or STAT3 Activation: Implication for Combinatorial Approach
Young-Kwang Yoon et al.
MOLECULAR CARCINOGENESIS (2010)
Pharmacogenomics of gemcitabine in non-small-cell lung cancer and other solid tumors
Romano Danesi et al.
PHARMACOGENOMICS (2009)
Modular tissue engineering: engineering biological tissues from the bottom up
Jason W. Nichol et al.
SOFT MATTER (2009)
Vascularization-The Conduit to Viable Engineered Tissues
Tamar Kaully et al.
TISSUE ENGINEERING PART B-REVIEWS (2009)
Gemcitabine and radiation therapy in non-small cell lung cancer: state of the art
F. Mornex et al.
ANNALS OF ONCOLOGY (2006)
Suberoylanilide hydroxamic acid combined with gemcitabine enhances apoptosis in non-small cell lung cancer
BK Rundall et al.
SURGERY (2005)
Caspase-3-mediated processing of poly(ADP-ribose) glycohydrolase during apoptosis
EB Affar et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)